Table 1 The baseline and final BCVA of the three groups of patients
BCVA | |||||
|---|---|---|---|---|---|
Patients number | NLP | LP-1.0 | 0.5–1.0(include 1.0) | 0.3–0.5(include 0.5) | ≤0.3 |
Group 1(before treatment) | 0 | 4 | 3 | 1 | 0 |
Group 1(after treatment) | 0 | 1 | 2 | 3 | 2 |
Group 2(before treatment) | 0 | 8 | 7 | 2 | 0 |
Group 2(after treatment) | 0 | 13 | 3 | 0 | 1 |
Group 3(before treatment) | 0 | 6 | 3 | 0 | 0 |
Group 3(after treatment) | 0 | 5 | 3 | 0 | 1 |